Dianbao Zhang
Luoyang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
High-Dose Aumolertinib for Untreated EGFR-Variant Non-Small Cell Lung Cancer With Brain Metastases: The ACHIEVE Phase 2 Nonrandomized Clinical Trial.
Journal: JAMA oncology
Published: June 26, 2025
Hydrophobicity causes anomalous migration of cystine/glutamate antiporter SLC7A11 in SDS-PAGE with low acrylamide concentration.
Journal: FEBS open bio
Published: September 25, 2024
Antiangiogenic therapy exerts antitumor effects by altering the tumor microenvironment: bibliometric analysis.
Journal: Frontiers in immunology
Published: July 06, 2024
Dysregulated expression of microRNA involved in resistance to osimertinib in EGFR mutant non-small cell lung cancer cells.
Journal: Journal of thoracic disease
Published: February 08, 2023
Combination of Decitabine and a Modified Regimen of Cisplatin, Cytarabine and Dexamethasone: A Potential Salvage Regimen for Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Treatment Failure.
Journal: Frontiers in oncology
Published: March 29, 2021
Long Non-Coding RNA NEAT1 Serves as Sponge for miR-365a-3p to Promote Gastric Cancer Progression via Regulating ABCC4.
Journal: OncoTargets and therapy
Published: January 10, 2020
Risk of venous and arterial thromboembolic events associated with anti-VEGF agents in advanced non-small-cell lung cancer: a meta-analysis and systematic review.
Journal: OncoTargets and therapy
Published: July 07, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026